Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+11.59%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$72.4B
AUM Growth
+$15.6B
(+27%)
Cap. Flow
+$9.69B
Cap. Flow
% of AUM
13.39%
Top 10 Holdings %
Top 10 Hldgs %
28.56%
Holding
1,592
New
27
Increased
724
Reduced
266
Closed
28
Top Buys
| 1 |
Microsoft
MSFT
|
+$679M |
| 2 |
UnitedHealth
UNH
|
+$592M |
| 3 |
NVIDIA
NVDA
|
+$471M |
| 4 |
Apple
AAPL
|
+$445M |
| 5 |
Amazon
AMZN
|
+$406M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$170M |
| 2 |
Danaher
DHR
|
+$129M |
| 3 |
Philip Morris
PM
|
+$117M |
| 4 |
Nike
NKE
|
+$37.7M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$12.6M |
Sector Composition
| 1 | Technology | 30.26% |
| 2 | Healthcare | 14.81% |
| 3 | Financials | 13.58% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Xencor
XNCR
$606M
| $270K | ﹤0.01% |
12,184
-541
| -4% | -$12K |
|
|
ALX
927
Alexander's
ALX
$1.25B
| $262K | ﹤0.01% |
1,205
| – | – |
|
928
ICICI Bank
IBN
$114B
| $259K | ﹤0.01% |
9,800
| – | – |
|
|
LAND
929
Gladstone Land Corp
LAND
$322M
| $259K | ﹤0.01% |
19,400
| – | – |
|
930
Q2 Holdings
QTWO
$5.17B
| $256K | ﹤0.01% |
4,878
-136
| -3% | -$7.15K |
|
931
HDFC Bank
HDB
$181B
| $256K | ﹤0.01% |
4,571
| – | – |
|
932
Amicus Therapeutics
FOLD
$2.47B
| $255K | ﹤0.01% |
21,688
-975
| -4% | -$11.5K |
|
|
LEV
933
DELISTED
The Lion Electric Company
LEV
| $255K | ﹤0.01% |
179,865
-14,037
| -7% | -$19.9K |
|
|
VERV
934
DELISTED
Verve Therapeutics
VERV
| $252K | ﹤0.01% |
19,013
-871
| -4% | -$11.6K |
|
935
Beam Therapeutics
BEAM
$2.18B
| $252K | ﹤0.01% |
7,640
-350
| -4% | -$11.6K |
|
936
Nu Holdings
NU
$75.5B
| $250K | ﹤0.01% |
20,951
-1,826
| -8% | -$21.8K |
|
937
Recursion Pharmaceuticals
RXRX
$2.12B
| $248K | ﹤0.01% |
24,914
-1,141
| -4% | -$11.4K |
|
938
Marathon Digital Holdings
MARA
$5.82B
| $248K | ﹤0.01% |
10,987
-1,051
| -9% | -$23.7K |
|
939
Regenxbio
RGNX
$479M
| $247K | ﹤0.01% |
11,732
-538
| -4% | -$11.3K |
|
940
IDEAYA Biosciences
IDYA
$2.18B
| $243K | ﹤0.01% |
5,545
-254
| -4% | -$11.1K |
|
941
Vir Biotechnology
VIR
$727M
| $243K | ﹤0.01% |
23,979
-1,099
| -4% | -$11.1K |
|
942
Rocket Companies
RKT
$44.4B
| $242K | ﹤0.01% |
16,625
-1,588
| -9% | -$23.1K |
|
943
Novartis
NVS
$247B
| $239K | ﹤0.01% |
2,467
-113
| -4% | -$10.9K |
|
944
Arrowhead Research
ARWR
$4.11B
| $239K | ﹤0.01% |
8,341
-373
| -4% | -$10.7K |
|
945
CONMED
CNMD
$1.67B
| $236K | ﹤0.01% |
2,953
-137
| -4% | -$11K |
|
|
NVEI
946
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $231K | ﹤0.01% |
7,296
-648
| -8% | -$20.5K |
|
947
PagSeguro Digital
PAGS
$2.77B
| $230K | ﹤0.01% |
16,122
-1,447
| -8% | -$20.7K |
|
948
CRISPR Therapeutics
CRSP
$5.08B
| $227K | ﹤0.01% |
3,332
-149
| -4% | -$10.2K |
|
949
Cipher Mining
CIFR
$3.92B
| $224K | ﹤0.01% |
43,527
-3,621
| -8% | -$18.6K |
|
950
LendingClub
LC
$1.92B
| $223K | ﹤0.01% |
25,388
-2,373
| -9% | -$20.9K |
|